| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1365-2133.1994.TB06088.X |
| P698 | PubMed publication ID | 8186136 |
| P2093 | author name string | Weidinger G | |
| Nolting S | |||
| Brautigam M | |||
| P2860 | cites work | The mechanism of action of terbinafine | Q38738808 |
| Onychomycosis | Q39885645 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | terbinafine | Q415259 |
| P304 | page(s) | 16-21 | |
| P577 | publication date | 1994-04-01 | |
| P1433 | published in | British Journal of Dermatology | Q4970191 |
| P1476 | title | Terbinafine in onychomycosis with involvement by non-dermatophytic fungi | |
| P478 | volume | 130 Suppl 43 |
| Q33824841 | A risk-benefit assessment of the newer oral antifungal agents used to treat onychomycosis |
| Q38006059 | An update on treatment of onychomycosis |
| Q35437556 | British Association of Dermatologists' guidelines for the management of onychomycosis 2014. |
| Q37450019 | Candida parapsilosis and Candida guillermondii: emerging pathogens in nail candidiasis |
| Q73235352 | Current Management of Onychomycosis and Dermatomycoses |
| Q41718745 | Current issues in onychomycosis |
| Q41321697 | Current management of onychomycosis. An overview |
| Q34019501 | Efficacy of fluconazole for the treatment of onychomycosis |
| Q33749017 | Facing up to the diagnostic uncertainty and management of onychomycoses |
| Q35604935 | Fatal Scopulariopsis brevicaulis infection in a paediatric stem-cell transplant patient treated with voriconazole and caspofungin and a review of Scopulariopsis infections in immunocompromised patients |
| Q36421636 | Fingernail Onychomycosis Due to Aspergillus niger |
| Q24645202 | Fungal nail disease: a guide to good practice (report of a Working Group of the British Society for Medical Mycology) |
| Q35211955 | How to improve cure rates for the management of onychomycosis |
| Q28379512 | In vitro activities of terbinafine against cutaneous isolates of Candida albicans and other pathogenic yeasts |
| Q58404969 | Itraconazole therapy is effective for pedal onychomycosis caused by some nondermatophyte molds and in mixed infection with dermatophytes and molds: A multicenter study with 36 patients |
| Q35127049 | Itraconazole versus terbinafine in the management of onychomycosis: an overview |
| Q34352760 | Long-term efficacy of antifungals in toenail onychomycosis: a critical review |
| Q35578703 | Management of Onychomycosis in Canada in 2014. |
| Q33726217 | Management of onychomycoses |
| Q35029719 | Nail disorders: unapproved treatments |
| Q35131544 | Non-dermatophyte onychomycosis |
| Q46238212 | Non-dermatophytic molds as agents of onychomycosis in Izmir, Turkey - a prospective study |
| Q40993014 | Onychomycosis Caused by Chaetomium globosum |
| Q35942309 | Onychomycosis caused by Scopulariopsis brevicaulis: report of two cases |
| Q46931411 | Onychomycosis in Rome, Italy |
| Q34000895 | Onychomycosis in the elderly |
| Q34184524 | Onychomycosis. New therapies for an old disease |
| Q33721371 | Onychomycosis: a compendium of facts and a clinical experience |
| Q33975323 | Onychomycosis: pathogenesis, diagnosis, and management |
| Q52251500 | Pharmacoeconomic analysis of oral antifungal therapies used to treat dermatophyte onychomycosis of the toenails. A US analysis. |
| Q34503639 | Recent advances in dermatology |
| Q41121162 | Recent developments in antifungal therapy |
| Q37888748 | Recent updates in oral terbinafine: its use in onychomycosis and tinea capitis in the US. |
| Q34779001 | Review of antifungal therapy and the severity index for assessing onychomycosis: part I. |
| Q31825121 | Systemic antifungal therapy |
| Q34004695 | Terbinafine, a unique oral antifungal: current perceptions |
| Q28370491 | Terbinafine. An update of its use in superficial mycoses |
| Q41674270 | Terbinafine: an update |
| Q33775734 | The new oral antifungal agents for onychomycosis of the toenails |
| Q28299342 | Treatment of Candida nail infection with terbinafine |
| Q33972502 | Utility of inoculum counting (Walshe and English criteria) in clinical diagnosis of onychomycosis caused by nondermatophytic filamentous fungi |
Search more.